We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NPAC:NASDAQNew Providence Acquisition Corp. III Analysis

Data as of 2026-07-05 - not real-time

$10.36

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

NPAC is trading at $10.36, just above its 20‑day SMA of 10.37 and marginally above the 50‑day SMA, indicating a modest bullish bias. The RSI sits near 48, suggesting neither overbought nor oversold conditions. Volume is increasing while the price remains confined between a clear support at 10.35 and resistance at 10.38, reinforcing the short‑term technical setup. The MACD histogram is slightly negative and the signal line is bearish, tempering the bullish momentum. Volatility over the past 30 days is low at about 1 %, and beta is virtually zero, implying the stock moves independently of broader market swings. However, the company has no operating revenue, negative book value, and a trailing PE of 33 versus an industry average of 17, highlighting a valuation disconnect.
The SPAC structure provides no dividend and the balance sheet shows cash of $324 k with no debt, but operating cash flow is strongly negative, underscoring the absence of a sustainable business. The only material news is a generic description of NPAC as a blank‑check vehicle, offering no near‑term catalyst. With extreme greed sentiment (Fear & Greed Index 93) and a market cap near $398 M, the stock appears overvalued and speculative. Investors should therefore treat the position as high‑risk, focusing on the technical support level and awaiting a definitive merger announcement before committing capital.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price above short‑term SMA
  • support level at 10.35
  • increasing volume

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • overvalued relative to earnings
  • no operating business
  • lack of merger catalyst

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • persistent negative book value
  • high valuation risk
  • speculative SPAC structure

Key Metrics & Analysis

Financial Health

P/E Ratio33.4
P/B Ratio-32.9
Op. Cash Flow$-1087533
Industry P/E17.5

Technical Analysis

TrendBullish
RSI47.9
Support$10.35
Resistance$10.38
MA 20$10.37
MA 50$10.35
MA 200$10.29
MACDBearish
VolumeIncreasing
Fear & Greed Index93.2

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.02
Volatility1.02%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.